Aemetis (NASDAQ:AMTX – Get Free Report) had its price target reduced by equities research analysts at Stifel Nicolaus from $10.00 to $7.50 in a report released on Monday, Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 58.90% from […]